Clinical Trials Logo

Clinical Trial Summary

This is an observational and cross-sectional study on the height loss, kyphosis indicators, bone mineral density and vertebral fractures in Chinese postmenopausal women


Clinical Trial Description

Postmenopausal women (N=255) aged ≥50 years were randomly selected from community centers in Changsha City, Hunan Province, China in September 2017. Menopause was defined as the absence of menstrual cycles for at least one year. All subjects were noninstitutionalized and in good health.The criteria for exclusion were morphological abnormalities or skeletal distortions that prohibited either clinical measurements or morphometric assessments of skeletal radiographs All participants were interviewed using a standard questionnaire. Body weight and height were measured to the closest 0.1 kg and 0.5 cm, respectively, with subjects wearing light clothing and no shoes. Current height was measured using a wall-mounted stadiometer, with a horizontal plate pressed on the head, and hair flattened. All subjects provided basic information, including current age, age at the start of menopause, years since menopause (YSM), weight, and their tallest recalled height. The current measured height subtracted from the tallest recalled height was subjects' HHL.The RPD, which was the vertical distance between the lowest margin of the ribs and the superior surface of the iliac crest along the mid-axillary line, was measured twice by a physician who stood behind the subject. For the kyphosis assessment, subjects were measured without shoes, with their heels, buttocks, and back to the wall, and head in a horizontal position with a double chin shown. The wall-occiput distance was defined as the horizontal distance between the wall and the back of the head. The distance between the prominence of the 7th cervical vertebra and the wall was defined as 7th cervical vertebra-wall distance (C7WD) , and wall-tragus-distance (WTD) was defined as the horizontal distance from the participant's tragus to the wall . All RPD and anthropometric indicators of kyphosis were measured in increments of 0.1 cm by two trained physicians.BMD of the lumbar spine, left femoral neck, and total hip were measured using dual energy X-ray absorptiometry. VFs were assessed using lateral spine imaging from T4 to L4 on X-ray. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03798444
Study type Observational
Source Central South University
Contact
Status Completed
Phase
Start date September 1, 2017
Completion date September 30, 2017

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06024148 - Continuation of Anti-osteoporotic Treatment 1 Year After Initial Administration
Completed NCT03710889 - Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption Phase 3
Recruiting NCT05058976 - Romosozumab Use to Build Skeletal Integrity Phase 4
Completed NCT04960033 - Evaluating Fracture Risk Assessment Tools (FRAX) From Different Regions in Central South Chinese Postmenopausal Women
Not yet recruiting NCT04597931 - Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density Phase 4
Completed NCT05366621 - Post-fracture Medication and Mortality
Completed NCT02483286 - Osteoporosis and Fall Prevention With Multiple Interventions in the Metropolitan Area N/A
Enrolling by invitation NCT03178799 - Randomized Fracture Liaison Services
Completed NCT02803190 - Osteoporosis and Fall Prevention and Posture Correction Interventions in the Metropolitan Area N/A
Recruiting NCT03451305 - Postrual Reduction With Pillow in Osteoporotic Vertebral Fracture N/A
Recruiting NCT03811509 - Breast Cancer Women on Aromatase Inhibitors Treatment Phase 4
Recruiting NCT06379243 - Development and Validation of a Postoperative Re-fracture Risk Model for Osteoporotic Spinal Fractures N/A